Prognostic significance of p16/CDKN2A deletion in pleural mesotheliomas

被引：0
|
作者：
Dacic, S.
Poppei, H. H.
Kothmaier, H.
Halbwedt, I.
Morbini, P.
Murer, B.
Comin, C. E.
Galateau-Salle, F.
Demirag, F.
Zeren, H.
Allanoos, R.
Gibbs, A.
Cagle, P. T.
机构：
[1] Univ Pittsburgh, Pittsburgh, PA 15260 USA
[2] Inst Pathol, Graz, Austria
[3] Inst Pathol Anat, Pavia, Italy
[4] Osped Umberto 1, Venice, Italy
[5] Univ Florence, I-50121 Florence, Italy
[6] CHU Cote Nacre, Caen, France
[7] Ataturk Chest Dis Hosp, Ankara, Turkey
[8] Adana Univ, Adana, Turkey
[9] Llandough Hosp, Cardiff & Vale NHS Trust, Cardiff, Wales
[10] Methodist Hosp, Houston, TX USA
来源：
MODERN PATHOLOGY | 2008年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1547
引用
收藏
页码：339A / 340A
页数：2
相关论文
共 50 条
  • [1] Prognostic significance of p16/CDKN2A deletion in pleural mesotheliomas
    Dacic, S.
    Popper, H. H.
    Kothmaier, H.
    Halbwedl, I.
    Morbini, P.
    Murer, B.
    Comin, C. E.
    Galateau-Salle, F.
    Demirag, F.
    Zeren, H.
    Attanoos, R.
    Gibbs, A.
    Cagle, P. T.
    LABORATORY INVESTIGATION, 2008, 88 : 339A - 340A
  • [2] Implications of P16/CDKN2A deletion in pleural mesotheliomas
    Ladanyi, M
    LUNG CANCER, 2005, 49 : S95 - S98
  • [3] Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomas
    Dacic, Sanja
    Kothmaier, Hannelore
    Land, Stephanie
    Shuai, Yongli
    Halbwedl, Iris
    Morbini, Patrizia
    Murer, Bruno
    Comin, Camilla
    Galateau-Salle, Francoise
    Demirag, Funda
    Zeren, Handan
    Attanoos, Richard
    Gibbs, Alan
    Cagle, Philip
    Popper, Helmut
    VIRCHOWS ARCHIV, 2008, 453 (06) : 627 - 635
  • [4] Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomas
    Sanja Dacic
    Hannelore Kothmaier
    Stephanie Land
    Yongli Shuai
    Iris Halbwedl
    Patrizia Morbini
    Bruno Murer
    Camilla Comin
    Françoise Galateau-Salle
    Funda Demirag
    Handan Zeren
    Richard Attanoos
    Alan Gibbs
    Philip Cagle
    Helmut Popper
    Virchows Archiv, 2008, 453 : 627 - 635
  • [5] FISH assay development for the detection of p16/CDKN2A deletion in malignant pleural mesothelioma
    Chung, Catherine T-S
    Santos, Gilda Da Cunha
    Hwang, David M.
    Ludkovski, Olga
    Pintilie, Melania
    Squire, Jeremy A.
    Tsao, Ming-Sound
    JOURNAL OF CLINICAL PATHOLOGY, 2010, 63 (07) : 630 - 634
  • [6] Global gene expression profiling of pleural mesotheliomas:: Overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction
    López-Ríos, F
    Chuai, S
    Flores, R
    Shimizu, S
    Ohno, T
    Wakahara, K
    Illei, PB
    Hussain, S
    Krug, L
    Zakowski, MF
    Rusch, V
    Olshen, AB
    Ladanyi, M
    CANCER RESEARCH, 2006, 66 (06) : 2970 - 2979
  • [7] CDKN2A/p16 in ependymomas
    Simona Bortolotto
    Loredana Chiadò-Piat
    Paola Cavalla
    Ivana Bosone
    Alessandro Mauro
    Davide Schiffer
    Journal of Neuro-Oncology, 2001, 54 : 9 - 13
  • [8] CDKN2A/p16 in ependymomas
    Bortolotto, S
    Chiadò-Piat, L
    Cavalla, P
    Bosone, I
    Mauro, A
    Schiffer, D
    JOURNAL OF NEURO-ONCOLOGY, 2001, 54 (01) : 9 - 13
  • [9] CDKN2A Deletion by FISH in Pleural and Peritoneal Mesotheliomas and Its Impact on Prognosis
    Marques-Piubelli, Mario L.
    Euscher, Elizabeth
    Ramalingam, Preetha
    Malpica, Anais
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1645 - S1645
  • [10] A Combination of MTAP and p16 Immunohistochemistry Can Substitute for CDKN2A Fluorescence In Situ Hybridization in Diagnosis and Prognosis of Pleural Mesotheliomas
    Brcic, Luka
    Le Stang, Nolwenn
    Gallob, Florian
    Pissaloux, Daniel
    Sequeiros, Ruth
    Paindavoine, Sandrine
    Pairon, Jean Claude
    Karanian, Marie
    Dacic, Sanja
    Girard, Nicolas
    Churg, Andrew
    Tirode, Franck
    Galateau-Salle, Francoise
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2023, 147 (03) : 313 - 322
12345